rs1555631387
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The NM_000371.4(TTR):c.206C>G(p.Thr69Ser) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T69A) has been classified as Pathogenic.
Frequency
Genomes: not found (cov: 32)
Consequence
TTR
NM_000371.4 missense
NM_000371.4 missense
Scores
10
7
2
Clinical Significance
Conservation
PhyloP100: 4.33
Genes affected
TTR (HGNC:12405): (transthyretin) This gene encodes one of the three prealbumins, which include alpha-1-antitrypsin, transthyretin and orosomucoid. The encoded protein, transthyretin, is a homo-tetrameric carrier protein, which transports thyroid hormones in the plasma and cerebrospinal fluid. It is also involved in the transport of retinol (vitamin A) in the plasma by associating with retinol-binding protein. The protein may also be involved in other intracellular processes including proteolysis, nerve regeneration, autophagy and glucose homeostasis. Mutations in this gene are associated with amyloid deposition, predominantly affecting peripheral nerves or the heart, while a small percentage of the gene mutations are non-amyloidogenic. The mutations are implicated in the etiology of several diseases, including amyloidotic polyneuropathy, euthyroid hyperthyroxinaemia, amyloidotic vitreous opacities, cardiomyopathy, oculoleptomeningeal amyloidosis, meningocerebrovascular amyloidosis and carpal tunnel syndrome. [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PM1
In a hotspot region, there are 12 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 7 uncertain in NM_000371.4
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr18-31595125-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 1454801.Status of the report is criteria_provided_single_submitter, 1 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.973
PP5
Variant 18-31595125-C-G is Pathogenic according to our data. Variant chr18-31595125-C-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 538164.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TTR | NM_000371.4 | c.206C>G | p.Thr69Ser | missense_variant | 3/4 | ENST00000237014.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TTR | ENST00000237014.8 | c.206C>G | p.Thr69Ser | missense_variant | 3/4 | 1 | NM_000371.4 | P1 | |
TTR | ENST00000649620.1 | c.206C>G | p.Thr69Ser | missense_variant | 5/6 | P1 | |||
TTR | ENST00000610404.5 | c.110C>G | p.Thr37Ser | missense_variant | 3/4 | 5 | |||
TTR | ENST00000541025.2 | n.232C>G | non_coding_transcript_exon_variant | 3/3 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Amyloidosis, hereditary systemic 1 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 10, 2017 | Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C55"). This variant has been reported in several individuals affected with hereditary amyloidosis (PMID: 25044787, 26115788, Invitae). This variant is also known as p.Thr49Ser in the literature. This variant is not present in population databases (ExAC no frequency). This sequence change replaces threonine with serine at codon 69 of the TTR protein (p.Thr69Ser). The threonine residue is highly conserved and there is a small physicochemical difference between threonine and serine. A different missense substitution at this codon (p.Thr69Ala) has been determined to be pathogenic (PMID: 1301926, 17503405, 20209591, 23713495, 21692911, 27859927). This suggests that the threonine residue is critical for TTR protein function and that other missense substitutions at this position may also be pathogenic. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D;D;T;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T;T;T
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
H;H;.;.
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;D;.;.
REVEL
Pathogenic
Sift
Uncertain
.;D;.;.
Sift4G
Uncertain
.;D;D;D
Polyphen
D;D;.;.
Vest4
0.83, 0.86, 0.93
MutPred
Gain of disorder (P = 0.115);Gain of disorder (P = 0.115);Gain of disorder (P = 0.115);Gain of disorder (P = 0.115);
MVP
1.0
MPC
1.3
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at